MS Walk

Virtual Research Poster Session

The Virtual Research Poster Session highlights the research of MS trainees and staff from across the country. Click on each research listing to learn more about how each researcher is helping to advance treatment and care, enhance well-being, understand and halt disease progression, and prevent MS.


A Ketogenic Diet Improves Clinical Scores in a Mouse Model of MS

Nima Alaeiilkhchi, University of British Columbia
Goal: Advance Treatment and Care


Humanizing mouse models of MS to evaluate Epstein Barr virus infection as a risk factor for disease

Jessica Allanach, University of British Columbia
Goal: Prevent MS


Il-1 Receptor Antagonist: A New Biomarker Found in Blood that Correlates with Disability and Neurofilament Light in Multiple Sclerosis

Stephanie Blandford, Memorial University of Newfoundland
Goal: Understand and Halt Disease Progression


Why does our society think it’s acceptable for younger adults with MS to live in long term care facilities? Using a Foucauldian genealogical approach to challenge the values in our care system.

Michelle Hewitt, University of British Columbia - Okanagan
Goal: Enhance Well-being


Neuregulin-1 is implicated in pathogenesis of multiple sclerosis and its availability ameliorates experimental autoimmune encephalomyelitis  

Hardeep Kataria, University of Manitoba
Goal: Understand and Halt Disease Progression


New theory shines light on how antibodies made by persons living with MS injure nerve cells

Cole Libner, University of Saskatchewan
Goal: Understand and Halt Disease Progression


Childhood Maltreatment May be Relevant to Pain Management in Multiple Sclerosis and Other Immune Disease 

Tyler MacDonald, Dalhousie University
Goal: Advance Treatment and Care


Impact of Dietary Methionine Restriction on Lymphocytes Ability to Invade the Brain and Spinal Cord in Neuroinflammation

Victoria Mamane, University of Montreal
Goal: Prevent MS


Metagenomic analysis of the pediatric multiple sclerosis microbiome

Ali Mirza, University of British Columbia
Goal: Prevent MS


Disease-modifying Drug Safety and Effectiveness in Multiple Sclerosis (DRUMS)

Huah Shin Ng, University of British Columbia
Goal: Advance Treatment and Care


A novel protein complex in Multiple Sclerosis

Tautvydas Paskevicius, University of Alberta
Goal: Understand and Halt Disease Progression


Prioritizing the Healthcare Access Concerns of Canadians with MS 

Julie Petrin, Queen's University
Goal: Enhance Well-being


Astrocytes: the cells with a "particular set of skills..."

Jacqueline Reid, University of Calgary
Goal: Understand and Halt Disease Progression


Childhood maltreatment and psychiatric comorbidity in multiple sclerosis and other immune mediated inflammatory disorders

Anthony Wan, University of Manitoba
Goal: Advance Treatment and Care


Making a favourable survival environment for protective immune cells inside the inflamed brain

Angela Wang, University of Toronto
Goal: Understand and Halt Disease Progression